NCT01055496 2019-08-02Study Evaluating Chemotherapy in Combination With Inotuzumab Ozogamicin In Subjects With Non-Hodgkin's LymphomaPfizerPhase 1 Completed103 enrolled 20 charts
NCT01232556 2019-01-08A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose ChemotherapyPfizerPhase 3 Terminated338 enrolled 15 charts